Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.95 -0.02 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Change in Accured Expenses (2022 - 2026)

Updated

Cadrenal Therapeutics' Change in Accured Expenses was $333,641 in Q2 2026, up 50.2% from $222,146 a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Change in Accured Expenses (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cadrenal Therapeutics' Change in Accured Expenses was -$210,126 through Jun 30, 2026; for FY2025, it came in at -$244,171.

  • In earlier years, Change in Accured Expenses was $543,284 in FY2024, -$225,645 in FY2023 and $863,622 in FY2022.
  • The Q2 2026 figure marks the highest quarterly Change in Accured Expenses since Q4 2024.
  • Compared with a year earlier, Change in Accured Expenses was higher in two of the last five quarters, with growth averaging 2.7%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q4 2024 (growth of 71.4%); the worst was Q4 2025 (a decline of 51.9%).
  • Per Business Quant data, CVKD's Change in Accured Expenses in the three quarters before Q2 2026 was -$697,176 (Q1 2026), $198,770 (Q4 2025) and -$45,361 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cadrenal Therapeutics 2.94 Mn -9.67 Mn - 333,641.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 333,641.00
Mar 31, 2026 -697,176.00
Dec 31, 2025 198,770.00
Sep 30, 2025 -45,361.00
Jun 30, 2025 222,146.00
Mar 31, 2025 -619,726.00
Dec 31, 2024 413,603.00
Sep 30, 2024 71,284.00
Jun 30, 2024 255,828.00
Mar 31, 2024 -197,431.00
Dec 31, 2023 241,290.00
Sep 30, 2023 124,810.00
Jun 30, 2023 13,199.00
Mar 31, 2023 -604,944.00
Dec 31, 2022 499,481.00
Sep 30, 2022 231,940.00
Jun 30, 2022 15,118.00
Mar 31, 2022 117,083.00
API Access

Cadrenal Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CVKD&period=max&api_key=YOUR_API_KEY